Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for the treatment of ADHD
IRCT20090117001556N162Phase 3Recruiting
- Sponsor
- Tehran University of Medical Sciences
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of pregabalin in attention deficit hyperactivity disorder (ADHD), sponsored by Tehran University of Medical Sciences. Started May 2025; status: recruiting.
02
Drugs
pregabalin
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on IRCT20090117001556N162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20090117001556N162.